AdamMBrufskyMD

Hematologic Oncology

Professor of Medical Oncology, University Pittsburgh

Overview of Dr. Brufsky

Dr. Adam Brufsky is an oncologist in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Presbyterian, UPMC Magee-Womens Hospital, and Shadyside Campus. He received his medical degree from University of Connecticut School of Medicine and has been in practice 27 years. Dr. Brufsky accepts several types of health insurance, listed below. He is one of 82 doctors at UPMC Magee-Womens Hospital and one of 144 doctors at UPMC Presbyterian who specialize in Oncology.

Office
300 Halket Street
Suite 4628
Pittsburgh, PA 15213
Book by Phone412-379-8910
Is this information wrong?

Education & Training

Dana-Farber Cancer InstituteFellowship, Medical Oncology, 1992 - 1995
Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1992
University of Connecticut School of MedicineClass of 1990

Certifications & Licensure

FL State Medical License 2012 - 2022
PA State Medical License 1996 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Pittsburgh Magazine Castle Connolly, 2005-2009
Top MD Consumers Checkbook
Most Compassionate Doctor American Registry
Join now to see all

Clinical Trials

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 01Brufsky, A.M.,Tolentino, A.R.,Hossain, A.M.,Thomas, A.,Karnad, A.B.,Fenton, A.H.,Sakr, B.J.,Marchello, B.T.,Ansari, B.,Friday, B.E.,O'Connor, B.M.,Sharer, C.W.,Kuzma, C.S.,Rose, C.G.,Reynolds, C.M.,Truica...
NSABP Biospecimen Discovery Project Start of enrollment: 2013 Jul 01Wolmark, N.,Brufsky, A.M.,Julian, T.B.,Tabchy, A.B.,Doyle, T.J.,Allegra, C.J.
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI Start of enrollment: 2013 May 01Brufsky, A.,Zibelli, A.,Wolff, A.,Nagarajan, A.,Kosowicz, A.,Haley, B.,Wagner, B.,Ramaswamy, B.,Head, B.,Steele, B.L.,Andrews, C.,McAleer, C.,Miller, C.,Wolfe, C.,Truica, C.,Francois, D.,Kettner-Sieber, D...
PRESENT: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer With Low to Intermediate HER2 Expressions With NeuVax™Treatment Start of enrollment: 2011 Nov 01Kenneth Deck, MD, William Audeh, MD, Andrea Stebel, MD, Richard Schwab, MD, Virginia Borges, MD, Suprith Badarinath, MD, Nikita Shah, MD, Elizabeth Tan-Chiu, MD, Hatem Soliman, MD, Jacqueline S. Jeruss, M...
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 01Brufsky, A.M.,Tolentino, A.R.,Hossain, A.M.,Lyss, A.P.,DeNittis, A.S.,Paterson, A.H.,Thomas, A.,Conlin, A.K.,Eisemann, A.D.,Zibelli, A.M.,McIntosh, A.F.,Hamad, A.,Sanyal, A.,Tiersten, A.D.,Tevaarwerk, A.J...
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 01Brufsky, A.M.,Tolentino, A.R.,Molins, A.B.,Lyss, A.P.,DeNittis, A.S.,Menter, A.,Urquhart, A.T.,Conlin, A.K.,Eisemann, A.D.,Zibelli, A.M.,Tabatabai, A.,Hernandez, A.L.,Karnad, A.B.,Robidoux, A.,Pippas, A.W...
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 01Brufsky, A.M.,Tolentino, A.R.,DeNittis, A.S.,Thomas, A.,Chung, A.,Conlin, A.K.,Zibelli, A.M.,Walker, A.P.,McIntosh, A.F.,Sanyal, A.,Fenton, A.H.,Figura, A.T.,Pippas, A.W.,McIntyre, A.P.,Drelichman, A.,Sch...

Publications & Presentations

PubMed

Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study.
Rohit Bhargava, Nicole Nicosia Esposito, Siobhan M OʹConnor, Zaibo Li, Bradley M. Turner, Ioana Moisini, Aditi Ranade, Ronald P Harris, Dylan V. Miller, Xiaoxian Li, H...> ;Modern Pathology. 2021 Jan 1
Viewpoint: Origin of SARS-CoV-2.
Lundstrom, K., Seyran, M., Pizzol, D., Adadi, P., El-Aziz, T. M., Hassan, S. S., Soares, A., Kandimalla, R., Tambuwala, M. M., Aljabali, A. A., Azad, G. K., Choudhury,...> ;Viruses. 2020 Oct 28
Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial.
Kathy S. Albain, Robert Gray, Della F. Makower, Amir Faghih, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, S...> ;Journal of the National Cancer Institute. 2020 Sep 28
Questions concerning the proximal origin of SARS-CoV-2.
Murat Seyran, Damiano Pizzol, Parise Adadi, Tarek Mohamed Abd El-Aziz, Sk. Sarif Hassan, Antonio Soares, Ramesh Kandimalla, Kenneth Lundstrom, Murtaza M. Tambuwala, Al...> ;Journal of Medical Virology. 2020 Sep 3
The Evolving Landscape of HER2-Directed Breast Cancer Therapy
Juan Luis Gomez Marti, Tara Hyder, Azadeh Nasrazadani, Adam Brufsky> ;Current Treatment Options in Oncology. 2020 Aug 7
Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor his...
Martin Blohmer, Li Zhu, Jennifer M. Atkinson, Sushil Beriwal, Joshua L. Rodríguez-López, Margaret Rosenzweig, Adam Brufsky, George C. Tseng, Peter C. Lucas, Adrian V. ...> ;Breast Cancer Research. 2020 Jun 26
The healthcare value of the Magee Decision Algorithm™: use of Magee Equations™ and mitosis score to safely forgo molecular testing in breast cancer.
Rohit Bhargava, Beth Z. Clark, Gloria Carter, Adam Brufsky, David J. Dabbs> ;Modern Pathology. 2020 Mar 17
Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs.
Melody A. Cobleigh, Denise A. Yardley, Adam Brufsky, Hope S. Rugo, Sandra M. Swain, Peter A. Kaufman, Debu Tripathy, Sara A. Hurvitz, Joyce O'Shaughnessy, Ginny Mason,...> ;Clinical Cancer Research. 2020 Mar 1
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analys...
Joseph A. Sparano, Robert Gray, Della F. Makower, Kathy S. Albain, Thomas James Saphner, Sunil Badve, Lynne I. Wagner, Virginia G. Kaklamani, Maccon M. Keane, Henry L....> ;JAMA Oncology. 2020 Mar 1
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors.
Neelima Vidula, Thereasa A. Rich, Oliver Sartor, Jennifer Yen, Aaron Hardin, Tracy Nance, Michael B. Lilly, M. A. Nezami, Sandip Pravin Patel, Benedito A. Carneiro, Al...> ;Clinical Cancer Research. 2020 Feb 7
Capivasertib inhibits a key pathway in metastatic breast cancer.
Azadeh Nasrazadani, Adam Brufsky> ;Lancet Oncology. 2020 Feb 5
The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network
Yujing J. Heng, Susan E. Hankinson, Jun Wang, Ludmil B. Alexandrov, Christine B. Ambrosone, Victor P. Andrade, Adam Brufsky, Fergus J. Couch, Tari A. King, Francesmary...> ;Cancer Epidemiology, Biomarkers & Prevention. 2020 Jan 13
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence.
Marcia V. Fournier, Edward C. Goodwin, Joan Chen, John C. Obenauer, Susan Tannenbaum, Adam Brufsky> ;Scientific Reports. 2019 Oct 16
CDK4/6 inhibitors: taking the place of chemotherapy?
Azadeh Nasrazadani, Adam Brufsky> ;Lancet Oncology. 2019 Sep 4
Artificial intelligence-directed prognostication of breast cancer
Azadeh Nasrazadani, Adam Brufsky> ;EBioMedicine. 2019 Aug 1
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Joseph A. Sparano, Robert Gray, Peter M. Ravdin, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Ma...> ;The New England Journal of Medicine. 2019 Jun 3
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
Maria J. Sambade, Grace Prince, Allison M. Deal, Dimitri G. Trembath, Megan Jean McKee, Amy Garrett, Kevin Keith, Juanita Ramirez, Bentley R. Midkiff, Kimberly L. Blac...> ;Breast Cancer Research and Treatment. 2019 Apr 23
Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.
Damir Vareslija, Nolan Priedigkeit, Ailis Fagan, Siobhan Purcell, Nicola Cosgrove, Philip J. O’Halloran, Elspeth Ward, Sinead Cocchiglia, Ryan J. Hartmaier, Carlos A. ...> ;Journal of the National Cancer Institute. 2019 Apr 1
A clinical decision support system learned from data to personalize treatment recommendations towards preventing breast cancer metastasis.
Xia Jiang, Alan Wells, Adam Brufsky, Richard E. Neapolitan> ;PLOS ONE. 2019 Mar 8
CACNG2 polymorphisms associate with chronic pain after mastectomy.
Andrey V. Bortsov, Marshall Devor, Mari A. Kaunisto, Eija Kalso, Adam Brufsky, Henrik Kehlet, Eske Kvanner Aasvang, Reinhard Bittner, Luda Diatchenko, Inna Belfer> ;Pain. 2019 Mar 1
Targeted mutation detection in breast cancer using MammaSeq
Nicholas G. Smith, Rekha Gyanchandani, Osama Shiraz Shah, Grzegorz T. Gurda, Peter C. Lucas, Ryan J. Hartmaier, Adam Brufsky, Shannon Puhalla, Amir Bahreini, Karthik K...> ;Breast Cancer Research. 2019 Feb 8
Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy.
Min Han, Arsalan Salamat, Li Zhu, Huina Zhang, Beth Z. Clark, David J. Dabbs, Gloria Carter, Adam Brufsky, Rachel C. Jankowitz, Shannon Puhalla, Ronald Johnson, Atilla...> ;Modern Pathology. 2019 Feb 5
Frequent ESR1 and CDK Pathway Copy Number Alterations in Metastatic Breast Cancer
Ahmed Basudan, Nolan Priedigkeit, Ryan J. Hartmaier, Ethan Sokol, Amir Bahreini, Rebecca J. Watters, Michelle M. Boisen, Rohit Bhargava, Kurt R. Weiss, MM Karsten, Car...> ;Molecular Cancer Research. 2019 Feb 1
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.
Yujing J. Heng, Jun Wang, Thomas U. Ahearn, Susan B. Brown, Xuehong Zhang, Christine B. Ambrosone, Victor P. Andrade, Adam Brufsky, Fergus J. Couch, Tari A. King, Fran...> ;Breast Cancer Research and Treatment. 2019 Feb 1
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, pha...
Eleftherios P. Mamounas, Hanna Bandos, Barry C. Lembersky, Jong-Hyeon Jeong, Charles E. Geyer, Priya Rastogi, Louis Fehrenbacher, Mark L. Graham, Stephen Chia, Adam Br...> ;Lancet Oncology. 2019 Jan 1
Join now to see all

Lectures

A Metastatic Breast Cancer Patient with Activating HER2 Exon 20 Insertion Mutation Responds to Poziotinib; A Case Report of Compassionate Drug Use
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Results from APHINITY Trial Using BluePrint® as a Biomarker Assay Presented at SABCS in Poster Spotlight DiscussionDecember 11, 2020 13:04
Monitoring Metastatic Breast Cancer Treatment Response: 5 Things to KnowDecember 08, 2020 12:12
Triple-Negative Breast Cancer: Expert Perspectives on Recent AdvancesOctober 24, 2020 18:58
Join now to see all

Grant Support

Safety Study Of Recombinant Monoclonal AntibodyNational Center For Research Resources1999–2002
Rhumabher2/Cyclophosphamide/Doxorubicin And Placebo/Cyclophosphamide/DoxorucinbNational Center For Research Resources1998–2002
Recombinant Humanized Anti-185her2 Monoclonal Antibody In Breast CancerNational Center For Research Resources1998–2002
Liposomal Annamycin In Taxane Resistant Breast CancerNational Center For Research Resources1999–2000
Androgen Receptor Associated Proteins In Prostate CancerNational Cancer Institute1996–1998
Androgen Receptor Associated Proteins In Prostate CancerNational Cancer Institute1995

Hospital Affiliations

UPMC PresbyterianPittsburgh, Pennsylvania
UPMC Magee-Womens HospitalPittsburgh, Pennsylvania
Shadyside CampusPittsburgh, Pennsylvania

Insurance Accepted

Aetna Choice POS II
BCBS Blue Card PPO
BCBS Wyoming BlueChoice Personal
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Great West PPO
HealthAmerica HealthAssurance PPO
Highmark BCBS ClassicBlue
Highmark BCBS PPOBlue
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment